MHRA and NICE invite early adopters to trial accelerated aligned pathway – six months ahead of schedule
Aligned pathway will streamline decisions on licensing and value for medicines, helping patients to benefit from them sooner.
Aligned pathway will streamline decisions on licensing and value for medicines, helping patients to benefit from them sooner.